Cost analysis of different cervical cancer screening strategies in Mexico
Objective. To compare the costs and number of undetected cases of four cervical cancer screening strategies (CCSS) in Mexico. Materials and methods. We estimated the costs and outcomes of the following CCSS: a) conventional Papanicolaou smear (Pap) alone; b) high-risk human papilloma virus testing (...
Main Authors: | Christyn M Beal, Jorge Salmerón, Yvonne N Flores, Leticia Torres, Víctor Granados-García, Ellen Dugan, Eduardo Lazcano-Ponce |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Nacional de Salud Pública
2014-09-01
|
Series: | Salud Pública de México |
Subjects: | |
Online Access: | http://www.saludpublica.mx/index.php/spm/article/view/7374 |
Similar Items
-
Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study
by: Yanxia Zhao, et al.
Published: (2021-07-01) -
Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review
by: Rita Medeiros, et al.
Published: (2020-03-01) -
Prevalence and intra-type variation of human papillomavirus (HPV) infection in cervical cancers: a nationwide perspective of China.
Published: (2001) -
High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
by: Tae-Wook Kong, et al.
Published: (2020-03-01) -
Diagnosis of cervical cancer by a urine test
by: Anna Małgorzata Łopuszyńska, et al.
Published: (2019-08-01)